Horizon Therapeutics (HZNP) PT Raised to $60 at Stifel After Very Positive KOL Call
Tweet Send to a Friend
Stifel analyst Annabel Samimy raised the price target on Horizon Therapeutics (NASDAQ: HZNP) to $60.00 (from $50.00) after hosting a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
